Cost-Effectiveness of Umeclidinium/Vilanterol Versus Indacaterol/Glycopyrronium in Symptomatic patients with COPD in the UK - Milan 2023

New frontiers in chronic obstructive pulmonary disease characterisation and management

Chair(s): Augusta Beech, Alexander Mathioudakis

Session type: Poster session

Cost-Effectiveness of Umeclidinium/Vilanterol Versus Indacaterol/Glycopyrronium in Symptomatic patients with COPD in the UK

Stephen G Noorduyn

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Bronchodilator response assessed by spirometry and SPECT/CT in COPD.

Edward Jeagal

Poster

Abstract

Addressing treatable traits: a meta-analysis to assess the effect of N-acetylcysteine on respiratory symptoms and exacerbations in pre-COPD and COPD patients

Alberto Papi

Poster

Abstract

Cost-Effectiveness of Umeclidinium/Vilanterol Versus Indacaterol/Glycopyrronium in Symptomatic patients with COPD in the UK

Stephen G Noorduyn

Poster

Abstract

Real-world study of formoterol/budesonide delivered through BAI in COPD patients

Balamurugan Santhalingam

Poster

Abstract

Does corticosteroid intake increase the risk of Vitamin D deficiency in Tunisias COPD patients?

Asma Zargouni

Poster

Abstract

Impact of comorbidities on quality of sleep among Tunisian patients with chronic obstructive pulmonary disease

Houda Rouis

Poster

Abstract

Benralizumab increases time to recurrent exacerbations in COPD patients on triple therapy with frequent exacerbations and an eosinophilic phenotype

Dave Singh

Poster

Abstract

Medication success among real-world users of budesonide/glycopyrrolate/formoterol fumarate (BGF) for the management of COPD in a UK primary care population

Hana Mullerova

Poster

Abstract

Clinical effect of inhaled corticosteroid withdrawal in stable COPD Patients

Chung-yu Chen

Poster

Abstract

Regional variation of COPD burden in Alberta, Canada

Christopher Licskai

Poster

Abstract

Azithromycin maintenance therapy for prevention of Chronic Obstructive Pulmonary Disease Exacerbations

Deepansh Gupta

Poster

Abstract

Trends in severe COPD exacerbations and mortality following the introduction of ultra-long-acting bronchodilators: an interrupted time-series study between 2007 and 2018 in the province Quebec, Canada

Charles-antoine Guay

Poster

Abstract

Observance of long-term non-invasive ventilation in COPD: VentiObs study

Gilles Jebrak

Poster

Abstract

Clusters in chronic obstructive pulmonary disease based on inhaled corticosteroid treatment and pneumonia incidence a nationwide cohort study

Allan Klitgaard

Poster

Abstract

Current smoking reduces small airway eosinophil counts in COPD

Augusta Beech

Poster

Abstract

COPD and heart rhythm disturbances: Overview of supraventricular and ventricular arrhythmias

Daniela Buklioska Ilievska

Poster

Abstract

Clinical characteristics of patients with COPD in Hong Kong

Fanny W.s. Ko

Poster

Abstract

Clinical and functional effects of inhaled dual therapy umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease: a real-life study

Corrado Pelaia

Poster

Abstract

Clinical factors linked to the type of respiratory medication in COPD: Results from COSYCONET

Peter Alter

Poster

Abstract

Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Glycopyrrolate/Formoterol Fumarate (GLY/FOR) in Symptomatic Patients with COPD in the UK: The AERISTO trial

Stephen G Noorduyn

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}